Having trouble accessing articles? Reset your cache.

Oct. 23 Financial Quick Takes: Alexion buyback; plus RAPT, NeuroRX and Oyster Point

Billion-dollar buyback for Alexion
The board of Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) has approved a $1 billion

Read the full word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE